The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ADC Therapeutics, Inc. Common H0036K147 1,612 334,384 SH   SOLE   334,384 0 0
Amicus Therapeutics Inc. Common 03152W109 4,102 392,946 SH   SOLE   392,946 0 0
Arcutis Biotherapeutics inc Common 03969K108 4,915 257,185 SH   SOLE   257,185 0 0
Avadel Pharmaceuticals Plc Common 05337M104 2,066 412,363 SH   SOLE   412,363 0 0
AVROBIO, Inc. Common 05455M100 416 647,918 SH   SOLE   647,918 0 0
Biocryst Pharmaceuticals Inc. Common 09058V103 7,631 605,663 SH   SOLE   605,663 0 0
Black Diamond Therapeutics, Inc. Common 09203E105 405 239,888 SH   SOLE   239,888 0 0
Crinetics Pharmaceuticals Inc. Common 22663K107 7,163 364,710 SH   SOLE   364,710 0 0
Cullinan Oncology, Inc. Common 230031106 98,051 7,648,268 SH   SOLE   7,648,268 0 0
Cytokinetics Inc. Common 23282W605 9,361 193,205 SH   SOLE   193,205 0 0
ESSA Pharma, Inc. Common 29668H708 738 405,700 SH   SOLE   405,700 0 0
Edgewise Therapeutics, Inc. Common 28036F105 2,992 304,027 SH   SOLE   304,027 0 0
G1 Therapeutics, Inc. Common 3621LQ109 10,701 856,798 SH   SOLE   856,798 0 0
Geron Corporation Common 374163103 19,709 8,422,582 SH   SOLE   8,422,582 0 0
Harmony Biosciences Hldgs Inc. Common 413197104 6,058 136,780 SH   SOLE   136,780 0 0
Harpoon Therapeutics, Inc. Common 41358P106 3,101 3,196,707 SH   SOLE   3,196,707 0 0
Inhibrx, Inc Common 45720L107 22,976 1,279,995 SH   SOLE   1,279,995 0 0
Inozyme Pharma Inc. Common 45790W108 1,772 661,144 SH   SOLE   661,144 0 0
Intellia Therapeutics, Inc. Common 45826J105 20,952 374,409 SH   SOLE   374,409 0 0
Iovance Biotherapeutics Inc Common 462260100 16,286 1,700,000 SH   SOLE   1,700,000 0 0
Iveric Bio Inc Common 46583P102 18,837 1,050,000 SH   SOLE   1,050,000 0 0
iTeos Therapeutics, Inc. Common 46565G104 33,260 1,745,943 SH   SOLE   1,745,943 0 0
Madrigal Pharmaceuticals Inc Common 558868105 2,908 44,747 SH   SOLE   44,747 0 0
Merus N.V. Common N5749R100 18,394 918,310 SH   SOLE   918,310 0 0
Mirum Pharmaceuticals Inc. Common 604749101 2,045 97,322 SH   SOLE   97,322 0 0
Oncorus, Inc. Common 68236R103 2,020 2,377,031 SH   SOLE   2,377,031 0 0
Phathom Pharmaceuticals Inc Common 71722W107 2,142 193,326 SH   SOLE   193,326 0 0
Provention Bio Inc Common 74374N102 3,332 740,344 SH   SOLE   740,344 0 0
Reata Pharmaceuticals Inc Common 75615P103 4,500 179,058 SH   SOLE   179,058 0 0
REGENXBIO Inc. Common 75901B107 16,362 619,083 SH   SOLE   619,083 0 0
Repare Therapeutics, Inc. Common 760273102 19,891 1,639,849 SH   SOLE   1,639,849 0 0
Revolution Medicines, Inc. Common 76155X100 2,880 146,041 SH   SOLE   146,041 0 0
TCR2 Therapeutics, Inc. Common 87808K106 6,068 3,370,982 SH   SOLE   3,370,982 0 0
Travere Therapeutics Inc. Common 89422G107 6,812 276,460 SH   SOLE   276,460 0 0
Verastem, Inc. Common 92337C104 2,758 3,244,650 SH   SOLE   3,244,650 0 0
Verve Therapeutics, Inc Common 92539P101 21,839 635,792 SH   SOLE   635,792 0 0
Werewolf Therapeutics, Inc. Common 95075A107 10,770 2,388,011 SH   SOLE   2,388,011 0 0
Y Mabs Therapeutics, Inc. Common 984241109 6,398 443,702 SH   SOLE   443,702 0 0